News
MRFF backs UQ epilepsy research
UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.
Led by Professor Ernst Wolvetang, the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients.
The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies.
The funding has been provided through the MRFF’s Stem Cell Therapies grant scheme.
Media contactUQ Communications
communications@uq.edu.au
+61 429 056 139
Related articles
Staying physically active cuts risk of early death by 40 per cent
Adults who stay consistently active throughout their life can lower their risk of early death by up to 40 per cent, a global study led by The University of Queensland has found.
11 July 2025
Analysis
Medicinal cannabis is big business. But the latest clampdown won’t curb unsafe prescribing
Australia’s key regulator of health professionals has announced it’s clamping down on unsafe prescribing of medicinal cannabis in the wake of surging patient demand.
10 July 2025